Wednesday, June 4, 2014

Checkpoint inhibitors... WTF? Is targeted approach dead???

Another THE thing in novel oncology Products development: http://www.fool.com/investing/general/2014/06/02/asco-2014-doubling-down-on-next-gen-cancer-drugs.aspx

Checkpoint inhibitors act by removing built-in brakes on the immune system to boost the response to tumor cells.

No comments:

Post a Comment